Galectin Therapeutics Stock Forecast

Buy or Hold candidate since Jun 18, 2026 Gain 53.27%

The Galectin Therapeutics Inc. stock price fell by -6.68% on the last day (Wednesday, 1st Jul 2026) from $4.64 to $4.33. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.71% from a day low at $4.28 to a day high of $4.61. The price has risen in 6 of the last 10 days and is up by 64.02% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -476 thousand shares and in total, 647 thousand shares were bought and sold for approximately $2.80 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 36.91% during the next 3 months and, with a 90% probability hold a price between $3.69 and $6.92 at the end of this 3-month period.

GALT Signals & Forecast

The Galectin Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.31 and $2.84. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 26, 2026, and so far it has fallen -13.23%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Galectin Therapeutics Inc. stock

Galectin Therapeutics Inc. finds support from accumulated volume at $4.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.330 between high and low, or 7.71%. For the last week, the stock has had daily average volatility of 13.43%.

Our recommended stop-loss: $4.10 (-5.42%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 79 and this increases the risk substantially. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (GALT) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Galectin Therapeutics Inc. to open at $4.41, and during the day (based on 14 day Average True Range), to move between $4.14 and $4.52, which gives a possible trading interval of +/-$0.381 (+/-9.21%) up or down from last closing price. If Galectin Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 9.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.23 (2.31%) than the resistance at $4.64 (7.16%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Galectin Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Galectin Therapeutics Inc. stock to perform well in the short-term.

Current score: 2.409 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 2, 2026 - $4.41 ( 1.77%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk